Top Stories World Malaysia Business Technology Entertainment Sports Health
  1. We'll study Sinovac clinical trial data before approving vaccine, says Khairy  Free Malaysia Today
  2. Indonesian President Joko Widodo receives Sinovac COVID-19 vaccine  CNA
  3. Deal's off if vaccine doesn't pass muster, KJ assures amid doubts about Sinovac  Malaysiakini
  4. Khairy: Govt will not go through with vaccine procurement if not satisfied with safety, efficacy  The Star Online
  5. Chinese coronavirus vaccine shows 50pct efficacy in Brazil  New Straits Times
  6. View Full coverage on Google News

A Phase III clinical trial in Brazil finds Sinovac vaccine to be only 50.4 percent efficacious.

KUALA LUMPUR, Jan 13 ― Malaysia, which is negotiating supplies of a Covid-19 vaccine with China’s Sinovac Biotech, will only go ahead with procurement if it satisfies the safety and efficacy standards of local regulators, a minister said on Wednesday. Brazil has triggered concerns over...KUALA LUMPUR, Jan 13 ― Malaysia, which is negotiating supplies of a Covid-19 vaccine with China’s Sinovac Biotech, will only go ahead with procurement if it satisfies the safety and efficacy standards of local regulators, a minister said on Wednesday. Brazil has triggered concerns over...

Khairy: Malaysia to study Sinovac clinical trial data before approving Covid-19 vaccine | Malaysia | Malay Mail

PETALING JAYA: Khairy Jamaluddin has said that the government would not go through with the procurement of Sinovac’s Covid-19 vaccine if they were not satisfied with its safety and efficacy.PETALING JAYA: Khairy Jamaluddin has said that the government would not go through with the procurement of Sinovac’s Covid-19 vaccine if they were not satisfied with its safety and efficacy.

Khairy: Govt will not go through with vaccine procurement if not satisfied with safety, efficacy | The Star

DELAYS in the distribution of Covid-19 vaccines in Malaysia have been attributed to the absence of clinical trials at home, according to Science, Technology and Innovation Minister Khairy Jamaluddin Abu Bakar (picture).The country is currently behind Indonesia, Brazil and Turkey, in its preparation to rollout millions of doses of Covid-19 vaccines, the minister said.Several companies from China last year pulled out from taking part in human clinical trials for Covid-19 vaccines in Malaysia due to the country’s declining number of active cases at the time.DELAYS in the distribution of Covid-19 vaccines in Malaysia have been attributed to the absence of clinical trials at home, according to Science, Technology and Innovation Minister Khairy Jamaluddin Abu Bakar (picture).The country is currently behind Indonesia, Brazil and Turkey, in its preparation to rollout millions of doses of Covid-19 vaccines, the minister said.Several companies from China last year pulled out from taking part in human clinical trials for Covid-19 vaccines in Malaysia due to the country’s declining number of active cases at the time.

Khairy: Vaccine plan delayed by absence of trials

Brazilian President Jair Bolsonaro said on Wednesday he was right to criticize the credibility of a Chinese COVID-19 vaccine developed by Sinovac Biotech that posted disappointing efficacy results in local trials.Brazilian President Jair Bolsonaro said on Wednesday he was right to criticize the credibility of a Chinese COVID-19 vaccine developed by Sinovac Biotech that posted disappointing efficacy results in local trials.

Brazil's Bolsonaro says he was right to question Chinese COVID-19 vaccine | Reuters

Indonesia’s vaccination program is the first large-scale use outside of China of the Sinovac Biotech Ltd. vaccine. Indonesia’s vaccination program is the first large-scale use outside of China of the Sinovac Biotech Ltd. vaccine. 

Indonesia Starts Mass COVID Vaccinations Over Vast Territory – The Diplomat

Indonesia leader gets nation's first coronavirus jabIndonesia leader gets nation's first coronavirus jab

Indonesia leader gets nation's first coronavirus jab - RFI

Indonesian President Widodo receives Chinese COVID-19 vaccine, starting country’s emergency-use rolloutIndonesian President Widodo receives Chinese COVID-19 vaccine, starting country’s emergency-use rollout

Indonesian President Widodo receives Chinese COVID-19 vaccine, starting country’s emergency-use rollout - The Washington Post

KUALA LUMPUR: The price of Sinovac vaccine developed by China is expected to be cheaper when the fill and finish process is carried out in Malaysia, Science, Technology and Innovation Minister Khairy Jamaluddin said.

Sinovac vaccine from China will cover 22 per cent of Msians | New Straits Times

A roundup of the latest developments of how the world is grappling with COVID-19A roundup of the latest developments of how the world is grappling with COVID-19

The announcement comes as confirmed COVID-19 infections continue to spike across the archipelago.The announcement comes as confirmed COVID-19 infections continue to spike across the archipelago.

Jokowi Receives First Shot as Indonesia Begins CoronaVac Roll-out – The Diplomat

Indonesia launched one of the world's biggest COVID-19 vaccination campaigns on Wednesday with President Joko Widodo receiving the first shot of the vaccine developed by Chinese biopharmaceutical company Sinovac Biotech.

Indonesian President Widodo receives Chinese COVID-19 vaccine - CGTN

President Joko Widodo received the first COVID-19 vaccine in a televised ceremony at the presidential palace in Jakarta on Wednesday.Indonesia will be a test case for the Sinovac Biotech vaccine, being the first country to administer CoronaVac for mass vaccination outside of China

Indonesia Begins COVID-19 Vaccine Rollout | Time

Health Minister Maksym Stepanov hopes that the situation with the coronavirus in Ukraine will become better in early summer. Lockdown was enforced in Ukraine from January 8.Lockdown was enforced in Ukraine from January 8.

Lockdown - Health chief insists on extending curbs beyond Jan 24 — UNIAN

Turkish authorities have given the go-ahead for the emergency use of the COVID-19 vaccine produced by China’s Sinovac Biotch LtdTurkish authorities have given the go-ahead for the emergency use of the COVID-19 vaccine produced by China’s Sinovac Biotch Ltd

Latest results show Sinovac's Covid-19 vaccine is less effective in Brazil than previously suggested.Latest results show Sinovac's Covid-19 vaccine is less effective in Brazil than previously suggested.

caret-down

Countries across the world have begun vaccination drives, mobilizing to protect their elderly and most vulnerable citizens from COVID-19, but Indonesia has...Countries across the world have begun vaccination drives, mobilizing to protect their elderly and most vulnerable citizens from COVID-19, but Indonesia has...

Why this country is vaccinating its working-age adults before the elderly - MarketWatch

President Joko Widodo this morning received a jab of the CoronaVac vaccine, officially launching Indonesia’s mass vaccination program against COVID-19 The vaccination ceremony was held at the Presidential Palace in Central Jakarta The president...President Joko Widodo this morning received a jab of the CoronaVac vaccine, officially launching Indonesia’s mass vaccination program against COVID-19 The vaccination ceremony was held at the Presidential Palace in Central Jakarta The president...

President Joko Widodo ushers Indonesia’s mass vaccination program with first CoronaVac jab | Coconuts Jakarta

Bloomberg - Are you a robot?

China’s CoronaVac COVID-19 vaccine produced by Sinovac has been proven safe and effective after phase III trials conducted in several countries, boosting public confidence over its global rollout as Indonesian President Joko Widodo received his first shot of the CoronaVac vaccine on Wednesday.

Sinovac’s vaccine proven safe and effective in several countries - Global Times

JAKARTA: Indonesia began its coronavirus vaccination drive on Wednesday, with President Joko Widodo receiving his first shot of a Chinese-produced vaccine.JAKARTA: Indonesia began its coronavirus vaccination drive on Wednesday, with President Joko Widodo receiving his first shot of a Chinese-produced vaccine.

Indonesia starts coronavirus vaccination drive, Jokowi gets first shot

China News: A coronavirus vaccine developed by China's Sinovac showed "general efficacy" of 50.4% in a late-stage trial in Brazil, researchers said on Tuesday, baChina News: A coronavirus vaccine developed by China's Sinovac showed "general efficacy" of 50.4% in a late-stage trial in Brazil, researchers said on Tuesday, ba

Brazil researchers report disappointing 50.4% efficacy for China's CoronaVac vaccine - Times of India

Millions around the world are about to be vaccinated with the Chinese Sinovac vaccine while some uncertainty remains about its efficacy.Millions around the world are about to be vaccinated with the Chinese Sinovac vaccine while some uncertainty remains about its efficacy.

Experts Question Efficacy of Chinese Vaccine Ahead of Rollout

China’s effort to boost its image by providing coronavirus vaccines to the developing world suffered a setback after one of its l...China’s effort to boost its image by providing coronavirus vaccines to the developing world suffered a setback after one of its leading inoculation candidates from Sinovac Biotech turned ou...

China's Sinovac vaccine comes up short in efficacy, Brazil says | The Standard

The vaccine will be free for all Indonesian citizensThe vaccine will be free for all Indonesian citizens

Indonesia starts mass COVID-19 vaccinations with president Joko Widodo | Asia – Gulf News

Efficacy questions about Sinovac Biotech’s Covid-19 vaccine are rising as shots are shipped to countries across the developing world for mass inoculation campaigns.  Indonesia has joined Braz…

China’s vaccine falls short of Western-set standard – Asia Times

In the largest trial of the private Chinese biotech firm's vaccine, it just crossed the efficacy cut-off set by many regulators.In the largest trial of the private Chinese biotech firm's vaccine, it just crossed the efficacy cut-off set by many regulators.

Sao Paulos Butantan biomedical center, which partnered with Sinovac to test and produce the vaccine in Brazil, dismissed the report as purely speculative as it prepares to release a more complete set of results on Tuesday.Sao Paulo’s Butantan biomedical center, which partnered with Sinovac to test and produce the vaccine in Brazil, dismissed the report as “purely speculative” as it prepares to release a more complete set of results on Tuesday.

Sinovac's vaccine efficacy less than 60% in Brazil trial - World - The Jakarta Post

Minister of Health of Turkey Fahrettin Koca said on January 7 in a statement that the efficacy rate of 78 percent in the Brazil trial is valid in moderate cases while the vaccine provides 100 percent efficacy in severe cases. Turkey argued that the CoronaVac provides 91.25 percent efficacy based on the country's interim results of a phase 3 trial conducted with volunteers between the ages of 18-59.Minister of Health of Turkey Fahrettin Koca said on January 7 in a statement that the efficacy rate of 78 percent in the Brazil trial is valid in moderate cases while the vaccine provides 100 percent efficacy in severe cases. Turkey argued that the CoronaVac provides 91.25 percent efficacy based on the country's interim results of a phase 3 trial conducted with volunteers between the ages of 18-59.

Turkey's choice Sinovac vaccine far less effective, says new Brazilian study | Ahval

Minister of Health of Turkey Fahrettin Koca said on January 7 in a statement that the efficacy rate of 78 percent in the Brazil trial is valid in moderate cases while the vaccine provides 100 percent efficacy in severe cases. Turkey argued that the CoronaVac provides 91.25 percent efficacy based on the country's interim results of a phase 3 trial conducted with volunteers between the ages of 18-59.Minister of Health of Turkey Fahrettin Koca said on January 7 in a statement that the efficacy rate of 78 percent in the Brazil trial is valid in moderate cases while the vaccine provides 100 percent efficacy in severe cases. Turkey argued that the CoronaVac provides 91.25 percent efficacy based on the country's interim results of a phase 3 trial conducted with volunteers between the ages of 18-59.

Turkey's choice Sinovac vaccine far less effective, says new Brazilian study | Ahval

The confusion, which comes as several governments commit to inoculating their citizens with Sinovac’s shot, is fueling skepticism over Chinese vaccines.The confusion, which comes as several governments commit to inoculating their citizens with Sinovac’s shot, is fueling skepticism over Chinese vaccines.

China’s COVID-19 shot has four wildly different efficacy rates | The Japan Times

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times

Efficacy rate of China-developed product barely sufficient to secure regulatory approval.Efficacy rate of China-developed product barely sufficient to secure regulatory approval.

search

NEW DELHI (AP) — India has started shipping COVID-19 vaccines to multiple cities, four days ahead of the nationwide inoculation drive. The first consignment of vaccines developed by the Serum Institute of India left the Indian city of Pune on Tuesday. The vaccines rolled out from Serum Institute of India’s facility in temperature-controlled trucks to … Continued

Asia Today: India starts shipping COVID-19 vaccine to cities - Egypt Independent

SAO PAULO (Reuters) -- A coronavirus vaccine developed by China's Sinovac Biotech was just 50.4% effective at preventing symptomatic infections in a BResults come as scientists slam biomed center for raising 'unrealistic' hopes

Sinovac vaccine disappoints at 50.4% efficacy: latest Brazil data - Nikkei Asia

Lower efficacy for Sinovac's vaccine still meets recognized threshold for emergency use, but barelyLower efficacy for Sinovac's vaccine still meets recognized threshold for emergency use, but barely

Third time’s the charm? Brazil scales back efficacy claims for COVID-19 vaccine from China | Science | AAAS

While its global rollout has kicked in with multiple South East Asian nations looking to expedite inoculation, uncertainty continues to swirl over its efficacy.While its global rollout has kicked in with multiple South East Asian nations looking to expedite inoculation, uncertainty continues to swirl over its efficacy.

COVID-19: China's Sinovac vaccine shows four efficacy rates, experts concerned

Attention Required! | Cloudflare

Attention Required! | Cloudflare

SINGAPORE: When the time comes, people should get themselves vaccinated with an approved vaccine, rather than hold out and wait for another brand, ...SINGAPORE: When the time comes, people should get themselves vaccinated with an approved vaccine, rather than hold out and wait for another brand, ...

Get vaccinated for COVID-19 when you can, instead of waiting for specific brand, says Lawrence Wong - CNA

The immunisation campaign aims to inoculate 181.5 million people, with the first to be vaccinated receiving the CoronaVac vaccine from China's Sinovac Biotech, which Indonesia authorised for emergency use on Monday.The immunisation campaign aims to inoculate 181.5 million people, with the first to be vaccinated receiving the CoronaVac vaccine from China's Sinovac Biotech, which Indonesia authorised for emergency use on Monday.

Indonesia president launches Covid-19 inoculation drive with Chinese vaccine | World News,The Indian Express